Answers are grounded in this paper and cite their sources.
The complex [ReO{η 3 -B(pz) 4 }(OMe) 2 ] ( 1 ) reacts with potentially bidentate protic substrates yielding several monomeric and dimeric oxorhenium compounds in which the tetrakis(pyrazolyl)borate presents different coordination modes: [ReO(acac){η 2 -B(pz) 4 }(OMe)] ( 3 ), [ReO(acac){η 2 -B(pz) 4 }] 2 (μ-O) ( 4 ), [ReO{η 2 -B(pz) 4 }(quinolin-8-olate)(OMe)] ( 5 ), [ReO{η 2 -B(pz) 4 }(OMe)(pz*)(pz*H)] (pz* = pz ( 6 ) or 3,5-Me 2 pz ( 7 )), [ReO{η 2 -B(pz) 4 }(μ-pz*)] 2 (μ-O) (pz* = pz ( 9 ) or 3,5-Me 2 pz ( 10 )), [ReO(HNCH 2 CH 2 NH){η 3 -B(pz) 4 }] ( 14 ), and [ReO( m -nitrophenyl- o -diaminate){η 3 -B(pz) 4 }] ( 15 ). Using the analogous alkoxide [ReO{η 3 -B(pz) 4 }(OEt) 2 ] ( 2 ), the compound [ReO{η 2 -B(pz) 4 }(OEt)(pz)(pzH)] ( 8 ) has also been obtained. Compounds 3 and 5 react with trimethylsilyl chloride providing the monochlorides [ReO(acac){η 2 -B(pz) 4 }Cl] ( 12 ) and [ReO{η 2 -B(pz) 4 }(quinolin-8-olate)Cl] ( 13 ), respectively. Compounds 9, 10, and 14 were also prepared by reacting [ReO(μ-O){B(pz) 4 }] 2 ( 11 ) with the respective substrates. The new compounds 3 − 10 and 12 − 15 were characterized by elemental analysis and IR and 1 H NMR spectroscopies. Compounds 3, 4, and 9 have also been characterized by X-ray crystallography. Compounds 3 and 4 both crystallize in the monoclinic space group P 2 1 / c, with a = 7.862(1) Å, b = 14.152(2) Å, c = 19.975(3) Å, β = 91.79(1)°, V = 2221(1) Å 3, and Z = 4 ( 3 ) and a = 13.547(2) Å, b = 9.959(1) Å, c = 15.878(2) Å, β = 102.00(1)°, V = 2095(1) Å 3 and Z = 2 ( 4 ). Compound 9 crystallizes in the monoclinic space group P 2 1, with cell parameters a = 11.086(2) Å, b = 15.269(1) Å, c = 12.133(1) Å, β = 93.51(1)°, V = 2050(1) Å 3 and Z = 2.
No takes yet. Share an insight, caveat, or question.
Paulo et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: